Resources

Supporting you to support your patients with hyperkalaemia

Report adverse events:

Adverse events should be reported to the Vifor Pharma group.
safety@viforpharma.com

Resources

Resources are available to help your patients control their K+ levels.

Some of these provide more information for you and some are for you to pass onto your patients to help them understand hyperkalaemia and the medicine they have been prescribed and what else they can do to help lower their K+ levels. 

Please click on the appropriate tab above to access the relevant resources.

 

For you

Electrolyte factsheet

Information on the relevance and impact of the 3 key electrolytes sodium, magnesium and calcium in the context of patients treated with Veltassa®.

resource

Veltassa algorithm for dosing

A visual guide for the dosing of Veltassa®.

resource

Checklist for treatment of chronic hyperkalemia

Checklist with the most important elements in the treatment of chronic hyperkalemia. The material is made in collaboration with two nephrologists and two dietitians in Sweden. For more info see the attachments. 

resource

Veltassa leaflet

A folder with info about a sodium free option with Veltassa in hyperkalemia treatments.

resource

MoA animation

A more in-depth look at how Veltassa® works.

FOR YOUR PATIENTS

Local Patient Material

A visual guide on how to take Veltassa®.

resource

References & footnotes

K+, potassium; MoA, mechanism of action.

CONSENT FORM FOR HCPS

If you, as an HCP, wish to receive electronic promotional and non-promotional information from the Vifor Pharma Group, please subscribe using this form.

Consent form for HCPs

If you, as an HCP, wish to receive electronic promotional and non-promotional information from the Vifor Pharma Group, please subscribe using this form.

*Required fields
Select the channels through which you agree to receive the communications and specify the corresponding contact details:
Please fill in all required fields
Please select a country
Please confirm that you have read Vifor Pharma Group's privacy notice
The email address is not correct
Make sure your number is correct, starting with "+" and the country code
Please select a communication channel
Please enter captcha
Captcha entered is not valid
Server Error - Your submission was not sent
Your message has been sent successfully
CAPTCHA
10 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
I hereby consent to receive communications from the Vifor Pharma Group, including promotional and non-promotional information, through the channels I have selected above, as specified in the Privacy Notice